PFPaola Frattaroli

Paola Frattaroli

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Paola Frattaroli has a total of 22 co-authors. Here are the top co-authors by number of shared publications:

  • Akina Natori

    Department of Medicine, Division of Medical Oncology University of Miami Miller School of Medicine Miami Florida USA

    2 shared publications
  • Anmary Fernandez

    Department of Medicine, Division of Infectious Disease University of Miami Miller School of Medicine Miami Miami Florida USA

    2 shared publications
  • Giselle Guerra

    University of Miami Miller School of Medicine, Miami Transplant Institute, Miami, Florida

    2 shared publications
  • Shweta Anjan

    Division of Infectious Diseases, University of Miami Miller School of Medicine and Miami Transplant Institute , Miami, Florida

    2 shared publications
  • Yoichiro Natori

    Division of Infectious Disease, Department of Medicine, University of Miami Miller School of Medicine , Miami, Florida

    2 shared publications
  • Anita Phancao

    Miami Transplant Institute Jackson Health System Miami Florida USA

    1 shared publication

Latest Publications

  • Difference between SARS‐CoV‐2, seasonal coronavirus, influenza, and respiratory syncytial virus infection in solid organ transplant recipients

    by Maria A. Mendoza, Gabriel Motoa, Mohammed A. Raja, Paola Frattaroli, Anmary Fernandez, Shweta Anjan, Steve C. Courel, Akina Natori, Cristopher B. O'BRien, Anita Phancao, et al.

    Background: Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) pandemic has been raging since the end of 2019 and has shown worse outcomes in solid organ transplant (SOT) recipients. The clinical differences as well as outcomes between respiratory viruses have not been well defined in this population.Methods: This is a retrospective cohort study of adult SOT recipients with nasopharyngeal swab or bronchoalveolar lavage PCR positive for either SARS‐CoV‐2, seasonal coronavirus, respiratory syncytial virus (RSV) or influenza virus from January 2017 to October 2020. The follow up period was 3 months. Clinical characteristics and outcomes were evaluated.Results: A total of 377 recipients including 157 SARS‐CoV‐2, 70 seasonal coronavirus, 50 RSV and 100 influenza infections were identified. The most common transplanted organ was kidney 224/377 (59.4%). Lower respiratory tract infection (LRTI) was found in 210/377 (55.7%) and the risk factors identified with multivariable analysis were SARS‐CoV‐2 infection, steroid use, and older age. Co‐ and secondary infections were seen in 77/377 (20.4%) recipients with bacterial pathogens as dominant. Hospital admission was seen in 266/377 (67.7%) recipients without significant statistical difference among viruses, however, ICU admission, mechanical ventilation and mortality were higher with SARS‐CoV‐2 infection. In the multivariable model, the risk factors for mortality were SARS‐CoV‐2 infection and older age.Conclusions: We found higher incidence of ICU admission, mechanical ventilation, and mortality among SARS‐CoV‐2 infected recipients. Older age was found to be the risk factor for lower respiratory tract infection and mortality for SARS‐CoV‐2, coronaviruses, RSV and influenza virus groups. image


  • Reinfection with SARS‐CoV‐2 in solid‐organ transplant recipients: Incidence density and convalescent immunity prior to reinfection

    by Stephen Morris, Shweta Anjan, Suresh Pallikkuth, Paola Frattaroli, Steve Courel, Anmary Fernandez, Akina Natori, Lilian Abbo, Savita Pahwa, Giselle Guerra, et al.

    Background: Long‐term protective immunity to severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) remains poorly characterized, particularly in solid organ transplant (SOT) patients.Method: We determined the incidence density of SARS‐CoV‐2 reinfection in a cohort of adult SOT recipients initially infected between March 1st, 2020 and March 30th, 2021 and included those with initial infection before or after transplantation. Incidence density was the total cases divided by total days after initial diagnosis with active graft.Results: Of 210 infected recipients, five (2.4%) developed reinfection, including two who had received full mRNA vaccination, but none developed hypoxia. The incidence density for reinfection was 9.4 (95% confidence interval [CI] 3.9‐22.6) and for primary infection the density was 9.1 (95% CI 7.9–10.5) cases/100,000 patient days. Two recipients had immunity evaluated in the weeks prior to reinfection, by measuring immunoglobulin‐G (IgG) antibody titer to the SARS‐CoV‐2 receptor binding domain and virus‐specific CD4+ and CD8+ T‐cell reactivity following stimulation with SARS‐CoV‐2 peptide pools. Both mounted virus specific CD4 T‐cell responses prior to reinfection (1.19% and 0.28% of total CD4 T cells) and both had reactive IgG testing (1.30 and 4.99 signal/cut off ratio).Conclusions: This suggests that SOT recipients infected with SARS‐CoV‐2 remain at high risk for reinfection even after generating cellular and humoral immune responses. image